Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $86.64 +1.23%
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $28.91 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
